Videos
World Alzheimer Day 2019: Key Takeaways From Leaders in Alzheimer Disease and Dementia
In recognition of World Alzheimer Day, experts in Alzheimer disease and dementia share insight from the latest Alzheimer Disease International's yearly World Alzheimer Report.
Danielle Andrade, MD, MSc: Education for Adult Neurologists on Pediatric-Onset Epilepsies
September 19th 2019The professor of medicine, neurology, at the University of Toronto discussed the best ways for adult neurologists to ensure a smooth transition of care for patients with epilepsy entering their care.
Jan Hillert, MD, PhD: The Blood-Brain Barrier in Multiple Sclerosis
September 19th 2019The professor and senior physician in the department of clinical neuroscience at the Karolinska Institutet discussed the evolving understanding of the blood-brain barrier in MS, and what might still be left to uncover.
Danielle Andrade, MD, MSc: Ensuring Smooth Transitions to Adult Epilepsy Care
September 18th 2019The professor of medicine, neurology, at the University of Toronto discussed the best ways for pediatric neurologists to ensure a smooth transition of care for patients with epilepsy who are leaving the pediatric system.
R. Edward Hogan, MD: Clinician Takeaways for Using Diazepam Nasal Spray
September 17th 2019The director of the adult epilepsy center at Washington University in St. Louis discussed the takeaways for clinicians regarding the use of intranasal diazepam as a treatment for runs of seizures in patients with refractory epilepsy.
Jan Hillert, MD, PhD: Treating the Non-Inflammatory Aspects of MS
September 16th 2019The professor and senior physician in the department of clinical neuroscience at the Karolinska Institutet spoke to the aspects of MS—such as brain volume loss—which are not currently being addressed by the available disease-modifying therapies.
Alberto Ascherio, MD, DrPH: Using Vitamin D to Treat MS
September 12th 2019The professor of epidemiology and nutrition at Harvard TH Chan School of Public Health discussed what might be an optimal dose of vitamin D supplementation in MS, and how vitamin D deficiency should be addressed as a modifiable risk factor.
Danielle Andrade, MD, MSc: Coordinating Epilepsy Care Transition Between Physicians
September 11th 2019The professor of medicine, neurology, at the University of Toronto discussed the need for physicians to work together while transitioning patients with epilepsy—who may have any number of comorbidities—from pediatric care to adult care.
Bruce Cree, MD, PhD, MAS: Exploring Clinical Utility of Siponimod, Fingolimod in MS
September 11th 2019The clinical research director of the UCSF Multiple Sclerosis Center discusses recent data on siponimod and its impact on cognitive measures in patients with secondary progressive MS, as well as results of the 3-arm ASSESS study comparing low-dose fingolimod and glatiramer acetate.
R. Edward Hogan, MD: Diazepam Nasal Spray Offers Benefits and Long-Term Safety
September 10th 2019The director of the adult epilepsy center at Washington University in St. Louis spoke about the use of diazepam nasal spray in patients with epilepsy ­and detailed the advantages it offers these patients and their physicians.
Danielle Andrade, MD, MSc: Transitioning Patients With Epilepsy to Adult Care
September 10th 2019The professor of medicine, neurology, at the University of Toronto spoke to the hurdles faced by both pediatric and adult neurologists when transitioning a patient with epilepsy from childhood care to adult care.
Paul Durham, PhD: A Combination Approach With nVNS in Migraine
September 6th 2019The distinguished professor and director of cell biology at Missouri State University discussed the use of nVNS in migraine treatment and whether or not it can replace the use of or be used in conjunction with triptans—a medication on which many patients fail or report poor response on.
